Glen Waverly, Australia

Luis Fernando Malaver-Ortega


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Glen Waverly, AU (2021)
  • Glen Waverly, AU (2020 - 2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Luis Fernando Malaver-Ortega

Introduction

Luis Fernando Malaver-Ortega is a notable inventor based in Glen Waverly, Australia. He has made significant contributions to the field of virology, particularly in the production of viruses in cell culture. With a total of 5 patents to his name, his work has implications for vaccine development and viral research.

Latest Patents

One of his latest patents focuses on the production of viruses in cell culture. This invention relates to methods of replicating viruses in vitro. Specifically, it involves a genetically modified population of cells, and/or a population of cells treated with an exogenous compound. These cells are capable of producing more virus than cells lacking the genetic modification and/or lacking treatment with the exogenous compound. The invention also encompasses methods for producing populations of such cells, as well as the use of the viruses obtained to prepare vaccine compositions.

Career Highlights

Throughout his career, Malaver-Ortega has worked with esteemed organizations such as the Commonwealth Scientific and Industrial Research Organisation and the University of Georgia Research Foundation, Inc. His research has been pivotal in advancing our understanding of viral replication and its applications in medicine.

Collaborations

He has collaborated with notable individuals in his field, including Andrew Bean and John William Lowenthal. These partnerships have contributed to the success of his research and innovations.

Conclusion

Luis Fernando Malaver-Ortega's work in the field of virology exemplifies the importance of innovation in medical research. His patents and collaborations continue to influence the development of effective vaccine strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…